Gladstone Institutional Advisory’s Idexx Laboratories IDXX Stock Holding History

Gladstone Institutional Advisory’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,633	Closed	-$817K	–	669
2023 Q1	$817K	Buy	+1,633	New	+$781K	0.05%	324
2022 Q4	–	Sell	-843	Closed	-$275K	–	666
2022 Q3	$275K	Sell	843 -2,636	-76%	-$968K	0.02%	519
2022 Q2	$1.22M	Buy	3,479 +1,903	+121%	+$776K	0.1%	237
2022 Q1	$862K	Sell	1,576 -1,714	-52%	-$902K	0.06%	323
2021 Q4	$2.17M	Sell	3,290 -831	-20%	-$522K	0.17%	162
2021 Q3	$2.56M	Buy	+4,121	New	+$2.77M	0.25%	114
2021 Q1	–	Sell	-1,115	Closed	-$557K	–	429
2020 Q4	$557K	Buy	1,115 +220	+25%	+$98.4K	0.11%	153
2020 Q3	$352K	Buy	+895	New	+$331K	0.08%	184

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Gladstone Institutional Advisory's IDXX Position: Q2 2023 in Review

Gladstone Institutional Advisory sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 1,633 shares — an estimated $817K sold.

Gladstone Institutional Advisory first reported a position in IDXX in Q3 2020 and held it in 8 quarters. The position peaked at $2.56M in Q3 2021. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

Gladstone Institutional Advisory reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
Gladstone Institutional Advisory sold 1,633 Idexx Laboratories shares in Q2 2023, an estimated $817K.
Gladstone Institutional Advisory first reported a position in Idexx Laboratories in Q3 2020 and held it in 8 quarters.
Gladstone Institutional Advisory's Idexx Laboratories position peaked at $2.56M in Q3 2021.
1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2023, filed 10 Aug 2023.